These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21282516)

  • 21. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
    Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
    J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling.
    Baker BM; Gagnon SJ; Biddison WE; Wiley DC
    Immunity; 2000 Oct; 13(4):475-84. PubMed ID: 11070166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
    Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
    Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.
    Utz U; Banks D; Jacobson S; Biddison WE
    J Virol; 1996 Feb; 70(2):843-51. PubMed ID: 8551623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.
    Ding YH; Baker BM; Garboczi DN; Biddison WE; Wiley DC
    Immunity; 1999 Jul; 11(1):45-56. PubMed ID: 10435578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
    Gagnon SJ; Turner RV; Shiue MG; Damirjian M; Biddison WE
    Mol Immunol; 2006 Feb; 43(4):346-56. PubMed ID: 16310048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996. 384: 134-141.
    Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
    J Immunol; 2010 Dec; 185(11):6394-401. PubMed ID: 21084668
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.
    Koenig S; Woods RM; Brewah YA; Newell AJ; Jones GM; Boone E; Adelsberger JW; Baseler MW; Robinson SM; Jacobson S
    J Immunol; 1993 Oct; 151(7):3874-83. PubMed ID: 7690819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire.
    Liang X; Weigand LU; Schuster IG; Eppinger E; van der Griendt JC; Schub A; Leisegang M; Sommermeyer D; Anderl F; Han Y; Ellwart J; Moosmann A; Busch DH; Uckert W; Peschel C; Krackhardt AM
    J Immunol; 2010 Feb; 184(3):1617-29. PubMed ID: 20042572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
    Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
    J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells.
    Rist MJ; Hibbert KM; Croft NP; Smith C; Neller MA; Burrows JM; Miles JJ; Purcell AW; Rossjohn J; Gras S; Burrows SR
    J Immunol; 2015 May; 194(10):4668-75. PubMed ID: 25855358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand.
    Davis-Harrison RL; Armstrong KM; Baker BM
    J Mol Biol; 2005 Feb; 346(2):533-50. PubMed ID: 15670602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant TCR-alpha requirements for a self antigen recognition in humans.
    Mantovani S; Palermo B; Garbelli S; Campanelli R; Robustelli Della Cuna G; Gennari R; Benvenuto F; Lantelme E; Giachino C
    J Immunol; 2002 Dec; 169(11):6253-60. PubMed ID: 12444131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner.
    Piepenbrink KH; Borbulevych OY; Sommese RF; Clemens J; Armstrong KM; Desmond C; Do P; Baker BM
    Biochem J; 2009 Oct; 423(3):353-61. PubMed ID: 19698083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How a single T cell receptor recognizes both self and foreign MHC.
    Colf LA; Bankovich AJ; Hanick NA; Bowerman NA; Jones LL; Kranz DM; Garcia KC
    Cell; 2007 Apr; 129(1):135-46. PubMed ID: 17418792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.
    Raman MC; Rizkallah PJ; Simmons R; Donnellan Z; Dukes J; Bossi G; Le Provost GS; Todorov P; Baston E; Hickman E; Mahon T; Hassan N; Vuidepot A; Sami M; Cole DK; Jakobsen BK
    Sci Rep; 2016 Jan; 6():18851. PubMed ID: 26758806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A structural basis of T cell cross-reactivity to native and spliced self-antigens presented by HLA-DQ8.
    Tran MT; Lim JJ; Loh TJ; Mannering SI; Rossjohn J; Reid HH
    J Biol Chem; 2024 Sep; 300(9):107612. PubMed ID: 39074636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously.
    Parker CE; Nightingale S; Taylor GP; Weber J; Bangham CR
    J Virol; 1994 May; 68(5):2860-8. PubMed ID: 7512153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.